DUBLIN--(BUSINESS WIRE)--The "Vascular Closure Devices Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering. The vascular closure devices market is ...

Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — While there is not yet definitive evidence that vascular closure devices produce better ...

New data presented Saturday at TCT 2014 show that, in patients undergoing transfemoral coronary angiography, vascular closure devices match manual compression in terms of vascular access site ...

Please provide your email address to receive an email when new articles are posted on . In an analysis of the ISAR-CLOSURE trial, use of vascular closure devices was as safe and effective as manual ...

- Passive approximators segment, femoral access segment are set to lay claim to a sizeable share of the market under the product and access type category, respectively - Asia-Pacific (APAC) will ...

BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...

NEW YORK, Oct. 29, 2019 /PRNewswire/ -- Vascular Closure Device market worldwide is projected to grow by US$413.8 Million, driven by a compounded growth of 6.6%. Passive Approximators, one of the ...

Patients who underwent surgery to repair punctured arteries had a significantly higher risk of complications when surgeons used a vascular-closure device manufactured by Cardinal Health, compared to ...

A head-to-head comparison of vascular closure devices defied expectations in the CHOICE-CLOSURE trial. For large-bore arterial access site closure after transfemoral transcatheter aortic valve ...

DUBLIN--(BUSINESS WIRE)--The "Vascular Closure Device Market | US | Units Sold, Average Selling Prices, Forecasts | 2018-2024 | MedCore" report has been added to ResearchAndMarkets.com's offering.

Chicago, IL - A new vascular closure device with a bioabsorbable plug has shown impressive results in a pivotal multicenter trial, ECLIPSE. The device, named ExoSeal (Cordis), also has a unique ...